ÂÜÀòÂÒÂ×

Tom Chan is a seasoned professional in drug metabolism and pharmacokinetics, currently serving as a Senior Research Fellow and previously holding various titles such as Senior Principal Scientist and Principal Scientist at Boehringer Ingelheim since January 2009. Prior experience includes a Postdoctoral Fellowship at CHUM, focusing on drug metabolism inhibition and ischemic liver damage, and a Doctoral candidacy at the University of Toronto in Pharmaceutical Science. Tom Chan holds a Postdoctoral degree from Université de Montréal and a Ph.D. in Pharmaceutical Science from the University of Toronto, along with a B.Sc. in Toxicology and Human Biology from the University of Trinity College.